Entasis Therapeutics

0 followers


Entasis Therapeutics is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients.

Industries

Employees

11-50

Links


Org chart

John Mueller
Chief Development Officer
Betzy Keiley
General Counsel

Board & advisors

Paul G Ambrose
Clinical Board Member
Mark Noe
Clinical Board Member
Karen Bush
Clinical Board Member
Louis B. Rice
Clinical Board Member
Andrew F. Shorr
Clinical Board Member
Helen W. Boucher
Clinical Board Member
Kerry Laplante
Clinical Board Member